Abstract Rheumatoid arthritis (RA) is associated with increased vascular calcification, although the rate of progress of calcification is uncertain. The aim of the study was to evaluate the progression of and the predictors for calcification in different vascular beds over 10 years. The 10-year actual coronary calcium score (CS) and 10-year predicted coronary CS, based on the pattern of the general population, were compared. Calcification of the coronary and carotid artery and the aorta was assessed by multi-detector computed tomography. Significant CS progression was determined by the difference between the square root of baseline and square root of follow-up calcium score (i.e., SQRT method). The 10-year predicted coronary CS was based on the mathematical formula derived by the Heinz Nixdorf Recall Study. A total of 49 patients (54 ± 11 years, 90% female) had a follow-up scan after 10.0 ± 0.2 years. The CS in all vascular beds was significantly increased; 55% of the patients had a significant progression of CS in the coronary, 29% in the carotid, and 80% in the aorta. Age and systolic blood pressure (SBP) were independently associated with calcification progression in all vascular beds. Importantly, the absolute increase in 10-year actual coronary CS was significantly higher than that predicted. In patients with RA, calcification in all vascular beds significantly increased over 10 years and was independently associated with age and SBP. Importantly, the absolute increase in 10-year actual coronary CS progression was significantly higher than that predicted.
Introduction
Patients with rheumatoid arthritis (RA) have an increased risk of premature death, largely due to cardiovascular causes; the risk of cardiovascular death is increased by up to 60% compared with the general population [1] [2] [3] [4] . The underlying mechanism is the development of premature atherosclerosis. A number of cross-sectional studies have shown that patients with RA have an increased prevalence and severity of coronary and other vascular bed calcification compared with controls [5] [6] [7] [8] .
In the general population, progression of vascular calcification is inevitable. A recent study showed that progression of coronary CS can be predicted accurately using a mathematical formula [9] . The rate of progression of vascular calcification in patients with RA is nonetheless unknown. The aim of the study was to evaluate the rate and predictors of calcification Dr. Liu and Ng contributed equally and shall be considered as co-first authors.
progression in various vascular beds, including the coronary and carotid artery and aorta over a 10-year period. In order to evaluate the pattern of coronary calcification progression in patients with RA, the absolute increase in 10-year actual coronary CS and 10-year predicted coronary CS (calculated based on the pattern of the general population) was compared.
Methods

Study population
Between January 2005 and December 2005, a total of 92 RA patients who fulfilled the American College of Rheumatology (formerly, the American Rheumatism Association) criteria were recruited. Patients with a history of cardiovascular disease including coronary artery disease (n = 4), myocardial infarction (n = 2), or stroke (n = 1) were excluded. [5] The final 85 RA patients underwent multi-detector computed tomography (MDCT) scan at baseline. Follow-up scan was not performed in patients who refused (n = 21), underwent coronary revascularization (n = 8), or died (n = 7) in the intervening period. A total of 49 patients underwent follow-up scan. The study was part of the Chinese Rheumatology Heart Disease Study (CRADS) to evaluate Chinese patients with rheumatic disease in an attempt to evaluate the cardiovascular manifestation, pathophysiology, and clinical outcome in these patients [10] . The Hong Kong West Cluster Ethic Committee approved the study (no. 785013), and written informed consent was obtained from all participants.
Study protocols
Baseline demographic and clinical characteristics were obtained through a complete physical examination and an interview, performed on the same day as the first MDCT scan. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured after patients had rested for at least 5 min. Body mass index (BMI) was calculated in kilograms per square meter. Vascular calcification risk factors including hypertension, diabetes, hyperlipidemia, and smoking were assessed as previously described [5, 11] . The 10-year Framingham Cardiovascular Risk Score using BMI was calculated for all patients [12] .
Fasting blood samples were obtained at baseline to measure total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, serum creatinine, and C-reactive protein. Data on medications were retrieved from patient electronic medical records, including anti-rheumatic treatment and cardiovascular events during follow-up.
Multi-detector computed tomography imaging
All subjects underwent cardiac, carotid artery, and aorta computed tomography scan using a 64-slice MDCT (LightSpeed, VCT; GE Healthcare, Milwaukee, WI, USA) as previously described [5, 11, 13] . In brief, all scans were performed with subjects in the supine position and covered the area from the base of the skull to just below the diaphragm. A prospective electrocardiogram gated cardiac scan was obtained with the following scan parameters: rotation time = 0.35 s, slice thickness = 2.5 mm, 120 kV, 250 mA, trigger delay = 70% R-R interval. Patients were instructed to hold their breath during scanning. Multi-detector computed tomography images were reviewed at the post-processing image workstation (Advantage Windows 4.02; GE Healthcare, USA). Complete data were available from all the scans, without missregistration of slices due to artifact, respiration, or asynchronous electrocardiographic triggering.
Analysis of MDCT CS
Measurement of CS was performed using a commercially available software Bsmart score^(GE Healthcare, USA) using the threshold option set for pixels >130 Hounsfield units. Coronary CS was calculated as the sum of CSs in the left main coronary artery, left anterior descending artery, left circumflex coronary artery, right coronary artery, and posterior descending artery. Carotid artery CS was calculated as the sum of CSs in the carotid arteries, including the common carotid artery, internal carotid artery, and bulb. Aortic CS was defined as the sum of CSs in the ascending and descending thoracic aorta in the scanning region. Total CS was the summation of coronary, carotid, and aortic CS.
Definition of significant CS progression
The difference between square root of baseline and square root of follow-up CS, known as BSQRT method,^has been proposed as a sensitive method to follow coronary calcification progression [14, 15] . This method was employed to calculate calcification progression in the coronary, carotid artery, and aorta. A square root transformed difference >2.5 was defined as significant CS progression.
Predicted coronary CS
The progression of artery calcification seems to be inevitable and follow an exponential curve. The Heinz Nixdorf Recall Study developed a software tool to estimate the future coronary CS beyond 10 years based on a patient's baseline age (limited to 45-79 years), gender, and coronary CS (limited to 0-1000 Hounsfield units). The CS calculation software has demonstrated high specificity and sensitivity for predictive value in general subjects [16] . In order to detect the influence of RA on coronary CS progression, we investigated the absolute increase in 10-year actual coronary CS and calculated 10-year predicted coronary CS. In the present study, one patient had a coronary CS above 1000 and 12 patients were beyond the age range for the calculation software. As a result, 36 patients met the conditions of the coronary CS calculation software (all with CS below 400 unit) and were used for analysis.
Statistical analysis
Data are expressed as mean ± standard deviation for continuous variables and frequencies or proportions for categorical variables. Student's t test was used to compare continuous variables of the two groups and chi-square test for categorical variables or Fisher's exact test if at least one cell had an expected count <5. The Mann-Whitney U test was used to evaluate statistical difference between absolute predicated increase in calcium score and actual increase in calcium score. Univariate and multivariate binary logistic regression analysis were performed to determine predictors of artery calcification progression. Parameters with a P value <0.10 in univariate analysis were entered into multivariate analysis using a forward method. The Framingham score was not included as the score is dependent on several of the parameters to be included in the multivariate analysis. Statistical analyses were performed using standard statistical computer software SPSS for Windows (Version 19.0). All P values reported are twosided for consistency, and P < 0.05 was considered statistically significant.
Results
Baseline demographics
At baseline, the mean age of the study population was 54 ± 11 years and the majority were female (90%). The mean disease duration was 13 ± 12 years, and the duration between first and follow-up scan was 10.0 ± 0.2 years. Cardiovascular risk factors at baseline were low: hyperlipidemia, n = 2 (4%); hypertension, n = 13 (27%); diabetes, n = 2 (4%); and smoking, n = 3 (6%). None of the patients were on biologic therapies. Other demongraphic data and medications the patients were prescribed are listed in Table 1 .
Clinical demographics in RA patients with and without CS progression
The CS in all vascular beds was significantly increased: coronary artery (58 ± 206 vs. 191 ± 439, P < 0.01), carotid artery (12 ± 51 vs. 92 ± 239, P < 0.01), aorta (111 ± 282 vs.
15 70 ± 280 6, P < 0. 01 ), a nd tota l (18 0 ± 44 3 vs.1851 ± 3150, P < 0.01). Significant progression of CS according to the SQRT method was as follows: coronary artery n = 27 (55%), carotid artery n = 14 (29%), and aorta n = 39 (80%). Patients who demonstrated coronary and carotid calcification at baseline were more likely to have significant CS progression compared with those with no baseline calcification (100 vs. 37%, P < 0.01; 86 vs. 19%, P < 0.01, respectively). In contrast, CS progression of the aorta occurred in both patients with and without baseline calcification (81 vs. 78%, P = 0.81).
Comparison of baseline clinical demographics between RA patients with and without CS progression in various vascular beds is shown in Table 1 . Patients with CS progression in the coronary, carotid artery, aorta, and total vascular bed were older and had a higher SBP, hypertension, and higher Framingham risk scores compared with those without CS progression. In addition, BMI was higher in patients with coronary CS progression, aortic CS progression, and total CS progression than in those without. The prevalence of hyperlipidemia was greater in patients with carotid CS progression compared with those without, and DBP and plasma total cholesterol were higher in patients with aortic and total CS progression. Further, duration of RA was longer in patients with aortic CS progression than in those without. Multivariable analyses for independent predictors of significant CS progression in individual vascular beds are shown in Tables 2, 3 , 4, and 5. Only age and SBP were associated with CS progression in all vascular beds.
Difference between baseline, 10-year predicted, and 10-year actual coronary CS progression
The absolute increase in 10-year actual coronary CS was significantly higher than the 10-year predicted increase (110.2 ± 165.3 vs. 63.5 ± 209.5, P = 0.01). The percentage of RA patients with significant actual coronary CS progression after 10 years was also higher than the predicted percentage (61 vs. 14%, P < 0.01). The distribution of different degrees of coronary CS (CS = 0, 1-10, 11-100, 101-400, and >400) at baseline, 10-year predicted, and 10-year actual is shown in Fig. 1 . At baseline, 28% patients had some level of coronary calcification, of whom 14% had coronary CS 1-10, 3% had coronary CS 11-100, and 6% had coronary CS 101-400, and none of the patients had coronary CS >400. The prevalence of those with coronary CS at level 11-100 (22 vs. 6%, P = 0.04) and 101-400 (25 vs. 3%, P = 0.01) was greater in the 10-year actual than the 10-year predicted group (Fig. 1) .
Discussion
The present study demonstrated that vascular calcification in the coronary artery, carotid artery, and aorta significantly increased in patients with RA over a 10-year period. Significant CS progression was most common in the aorta followed by the coronary and carotid artery. Compared with those without, patients with baseline calcification were more likely to have significant CS progression in both the coronary and carotid arteries. In contrast, patients with and without baseline calcification had a similar chance of developing significant CS progression in the aorta. Age, hypertension history, SBP, and the Framingham score were independent predictors of significant CS progression in all vascular beds. Finally, the absolute increase in 10-year actual coronary CS and the prevalence of significant coronary CS progression was higher than the 10-year predicted value calculated by the formula from the Heinz Nixdorf Recall Study.
Previous cross-sectional studies have shown that patients with RA, relative to unaffected individuals, have a 1.5-5-fold higher risk of vascular calcification detected by MDCT [5, 6, 17] . Further, the coronary CS is predictive of future adverse cardiovascular events [18] . In patients with RA, the progression of CS in different vascular beds has not been evaluated. Studies in the general population suggest that progression of vascular calcification, in particular in the coronary artery, is frequent [19, 20] . Importantly, those with significant coronary CS progression are at high risk of developing an adverse outcome [21] . Thus, prospective studies to evaluate the progression of vascular calcification in patients with RA are essential. The present study demonstrated that in these patients, over a decade, significant progression of calcification occurred not BMI body mass index, CRP C-reactive protein, DBP diastolic blood pressure, HCQ hydroxychloroquine, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, MTX methotrexate, RA rheumatoid arthritis, SBP systolic blood pressure, SSZ sulfasalazine, TC total cholesterol, TG triglyceride a OR cannot be estimated due to the complete separation of the data, so that we have no case from one of the groups b The Framingham risk score was not included in the multivariate analysis due to its lack of independence to the other risk factors only in the coronary artery but in all vascular beds. Prior studies in the general population have shown that those with baseline coronary [9] and carotid [19] calcification have a higher chance of disease progression. Similarly, the present study demonstrated that the prevalence of significant progression of calcification was up to 4-fold higher in patients with RA and baseline coronary and carotid calcification. Interestingly, this pattern was not observed in the aorta where progression of disease was similar between those with and without baseline aortic calcification. This finding is in line with our prior observation that patients with RA have preferential aortic calcification and suggests that baseline calcification plays a limited role in predicting disease progression in the aorta [5] . The prognostic value of aortic calcification has also been demonstrated in the general population but would nonetheless need verification in patients with RA [22] . Although systemic inflammation in patients with RA has been deemed a major factor for development of premature atherosclerosis, the role of conventional cardiovascular risk factors in this regard should not be ignored. A prior study by the Multi-Ethnic Study of Atherosclerosis demonstrated that old age, a high SBP, and triglyceride level were independently associated with coronary calcification progression in patients with RA [23] . Another study that evaluated the carotid intima and media thickness also showed that in addition to inflammation, a worse cardiovascular risk profile was associated with progression of atherosclerosis [24] . The present study further extends these findings, by showing that in patients BMI body mass index, CRP C-reactive protein, DBP diastolic blood pressure, HCQ hydroxychloroquine, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, MTX methotrexate, RA rheumatoid arthritis, SBP systolic blood pressure, SSZ sulfasalazine, TC total cholesterol, TG triglyceride a OR cannot be estimated due to the complete separation of the data, so that we have no case from one of the groups b The Framingham risk score was not included in the multivariate analysis due to its lack of independence to the other risk factors with RA, both age and SBP independently predicted CS progression in all vascular beds. It is worth noting that the mean SBP of those with progression of CS in different vascular beds was reasonably well controlled according to the current recommendation (between 133 and 143 mmHg) [25] . This suggests that controlling SBP to below 130 mmHg may provide additional protection against progression of atherosclerosis which would correlate with the recent SPRINT trial (includes SPRINT trial [26] which indicated a reduction in major adverse cardiovascular events with SBP below 130 mmHg). This would nonetheless require validation by future prospective study. The progression of coronary CS is inevitable and with a high explained variance that increases only slightly upon adjustment of cardiovascular risk factors. Coronary CS progression can be predicted as it follows an exponential curve, and a mathematical tool was subsequently proposed by the Heinz Nixdorf Recall Study [9] . Whether the progression of coronary CS in patients with RA resembles the general population is uncertain. A key finding of the present study was that the absolute increase in 10-year actual coronary CS was significantly higher than that predicted by the Heinz Nixdorf Recall Study formula. Further, the chance of having significant coronary CS progression in patients with RA was 4-fold higher than that predicted. This finding suggests that in patients with RA, the progression of coronary CS is more rapid and does not follow the predicted pattern of non-RA patients. The observed rapid progression of coronary CS is further BMI body mass index, CRP C-reactive protein, DBP diastolic blood pressure, HCQ hydroxychloroquine, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, MTX methotrexate, RA rheumatoid arthritis, SBP systolic blood pressure, SSZ sulfasalazine, TC total cholesterol, TG triglyceride a OR cannot be estimated due to the complete separation of the data, so that we have no case from one of the groups b The Framingham risk score was not included in the multivariate analysis due to its lack of independence to the other risk factors BMI body mass index, CRP C-reactive protein, DBP diastolic blood pressure, HCQ hydroxychloroquine, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, MTX methotrexate, RA rheumatoid arthritis, SBP systolic blood pressure, SSZ sulfasalazine, TC total cholesterol, TG triglyceride a OR cannot be estimated due to the complete separation of the data, so that we have no case from one of the groups b The Framingham risk score was not included in the multivariate analysis due to its lack of independence to the other risk factors Fig. 1 Percentage of coronary calcium score (CS) distribution at baseline, 10-year predicted, and 10-year actual. Abbreviations: CCS coronary artery calcium score evidence that patients with RA are prone to premature atherosclerosis and thus subsequent cardiovascular events.
Clinical implications
Although patients without coronary and carotid calcification are less likely to develop future calcification and progression, this does not apply to the progression of aorta calcification. Patients without aorta calcification may still have a high chance of disease and subsequent progression, in particular those who are older or who have high SBP. The present study demonstrated that SBP is a key predictor of CS progression in all vascular beds. Patients with RA should have strict control of SBP, preferably below 130 mmHg, in order to minimize CS progression. In addition, the Framingham score was a predictor of calcium score progression in all vascular beds which would be consistent with the multivariable analysis since the scoring takes into account age and SBP. The score also takes into account BMI, diabetes, and smoking status, but these risk factors individually except for BMI were not shown to be predictive of significant coronary artery calcification progression. Thus, focus should still be placed on reducing systolic blood pressure and managing the other risk factors. Therefore, dietary and lifestyle factors should also be encouraged in those patients with higher Framingham risk scores. Finally, the greater coronary CS progression in patients with RA confirms the need for close surveillance to prevent the development of adverse events.
Strength and limitations
One of the strengths of the present study is the long duration between scans. Given the exponential curve of calcification progression, this long period allows the development and detection of significant coronary CS progression compared with the pattern of those unaffected. This may also explain the negative result of a prior study that had only a short time between scans (3.2 years in RA patients and 2.3 years in controls) [23] . The present study is one of the few studies to evaluate the pattern of calcification progression in various vascular beds (most common in the aorta) and provide novel insight in this regard. There were nonetheless several limitations: the disease status was only assessed by the duration of disease, use of medication, and C-reactive protein level. Future studies that include DAS-28 will be necessary to evaluate the relation between disease activity and the progression of calcification. The present study only evaluated vascular calcification by non-contrast MDCT, and therefore, studies evaluating non-calcified plaque progression by contrast imaging will be necessary. Finally, patients evaluated in the present study were Asian; given the potential ethnic differences in atherosclerosis pattern, confirmatory studies in other ethnic groups are required [10] .
Conclusion
The present study demonstrated that calcification in all vascular beds significantly increased in patients with RA over a 10-year period and was independently associated with both SBP and age. Importantly, the absolute increase in 10-year actual coronary CS progression was significantly higher than the 10-year predicted increase.
